ToxSci Advance Access originally published online on September 21, 2005
Toxicological Sciences 2006 89(1):42-50; doi:10.1093/toxsci/kfi339
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FORUM SERIES |
Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles




* Exponent, Bellevue, Washington 98007;
Woodrow Wilson International Center for Scholars, Washington, DC 200043027;
National Center for Toxicological Research and National Toxicology Program Center for Phototoxicology, U.S. Food & Drug Administration, Jefferson, Arkansas 72079;
National Aeronautics and Space Administration, Houston, Texas 77058; ¶ DuPont Haskell Laboratory, Newark, Delaware 19714; || Environ International, Houston, Texas 77002
Received July 28, 2005; accepted September 20, 2005
Nanoparticles are small-scale substances (<100 nm) with unique properties and, thus, complex exposure and health risk implications. This symposium review summarizes recent findings in exposure and toxicity of nanoparticles and their application for assessing human health risks. Characterization of airborne particles indicates that exposures will depend on particle behavior (e.g., disperse or aggregate) and that accurate, portable, and cost-effective measurement techniques are essential for understanding exposure. Under many conditions, dermal penetration of nanoparticles may be limited for consumer products such as sunscreens, although additional studies are needed on potential photooxidation products, experimental methods, and the effect of skin condition on penetration. Carbon nanotubes apparently have greater pulmonary toxicity (inflammation, granuloma) in mice than fine-scale carbon graphite, and their metal content may affect toxicity. Studies on TiO2 and quartz illustrate the complex relationship between toxicity and particle characteristics, including surface coatings, which make generalizations (e.g., smaller particles are always more toxic) incorrect for some substances. These recent toxicity and exposure data, combined with therapeutic and other related literature, are beginning to shape risk assessments that will be used to regulate the use of nanomaterials in consumer products.
Key Words: nanotechnology; nanoparticles; risk assessment; exposure assessment.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Lison, L. C. J. Thomassen, V. Rabolli, L. Gonzalez, D. Napierska, J. W. Seo, M. Kirsch-Volders, P. Hoet, C. E. A. Kirschhock, and J. A. Martens Nominal and Effective Dosimetry of Silica Nanoparticles in Cytotoxicity Assays Toxicol. Sci., July 1, 2008; 104(1): 155 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flesken-Nikitin, I. Toshkov, J. Naskar, K. M. Tyner, R. M. Williams, W. R. Zipfel, E. P. Giannelis, and A. Yu. Nikitin Toxicity and Biomedical Imaging of Layered Nanohybrids in the Mouse Toxicol Pathol, October 1, 2007; 35(6): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. MAYNARD Nanotechnology: The Next Big Thing, or Much Ado about Nothing? Ann. Hyg., January 1, 2007; 51(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||


